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Abstract: Xylemin (6) and its designed structural analogues 18–23, 
N-(4-aminobutyl)alkylamines, were synthesized by 2-
nitrobenzenesulfonamide (Ns) strategy. Investigation of the 
improved synthesis of 20–23 resulted in the development of one-
step synthesis of these analogues from the commercially available 
corresponding ketones. Biological assessment of the synthetic 
molecules elucidated that xylemin (6) and the analogue N-(4-
aminobutyl)cyclopentylamine (21) promoted the expression level of 
thermospermine synthase ACAULIS5 (ACL5) and enhanced xylem 
formation. In addition, xylemin (6) was found to significantly promote 
lateral root formation, whereas xylemin analogues 18–23 including 
21 did not. These results indicate that the analogue 21 has the 
potential as a novel inhibitor of thermospermine synthesis to work 
specifically in xylem differentiation. 
Introduction 
Polyamines are low-molecular cationic compounds existing in all 
organisms. Polyamines regulate various biological processes 
including RNA/DNA stabilization, transcription of RNA, protein 
translation, and ion channel modulation through their binding 
with nucleic acids and proteins.[1] Putrescine (2), spermidine (3), 
and spermine (4) are commonly found in various species and 
recognized as major polyamines (Scheme 1). In plants, 
putrescine (2) is synthesized from L-arginine (1) through multiple 
reaction steps.[2] Spermidine (3) and spermine (4) are 
synthesized from putrescine (2) by sequential addition of an 
aminopropyl group via the catalytic action of aminopropyl 
transferases, spermidine synthase (SPDS) and spermine 
synthase (SPMS), respectively. The aminopropyl group is 
donated by decarboxylated S-adenosylmethionine. These 
polyamines are involved in various physiological phenomena 
during plant development and stress response, such as cell 
death, alkaloid biosynthesis, and organ growth.[3] 
Scheme 1. Biosynthetic pathways of polyamines in plants. 
Thermospermine (5) is a structural isomer of spermine (4) 
found in bacteria and plants.[4] Thermospermine (5) is generated 
from spermidine (3) through adding an aminopropyl group by the 
action of thermospermine synthase designated ACAULIS5 
(ACL5).[5] Because ACL5 gene is well conserved in plant 
kingdom from algae to angiosperms, thermospermine (5) is a 
ubiquitous plant polyamine, whereas spermine (4) and SPMS 
gene exist only in seed plants but not in algae, bryophytes, and 
monilophytes.[4b] Thus, thermospermine (5) is a major polyamine 
in plants. Thermospermine-deficient acl5 mutant of Arabidopsis 
thaliana exhibits excess xylem formation, which results in severe 
suppression of organ elongation.[6] Addition of exogenous 
thermospermine significantly suppresses xylem differentiation 
and recovers the defect of organ elongation in the acl5 
mutant.[5b] These studies indicate that thermospermine (5) is a 
unique plant growth regulator for limiting xylem differentiation 
and promoting organ growth. 
Thermospermine (5) is not only a key regulator for plant 
growth but also a powerful bioactive molecule to modulate plant 
yield and biomass. However, its biological function has been 
studied only in angiosperms, especially in Arabidopsis. To 
investigate thermospermine function in various plants, we 
decided to develop the inhibitor of thermospermine biosynthesis. 
We previously reported chemical synthesis of the molecule to 
inhibit thermospermine biosynthesis and named this biologically 
active molecule xylemin.[7] Xylemin (6) is a spermidine analogue, 
N-(4-aminobutyl)propylamine, which loses an amino group 
required for the addition of the aminopropyl group in 
thermospermine biosynthesis (Figure 1). Xylemin (6) 
competitively inhibits biosynthesis of thermospermine (5) and 
promotes xylem differentiation in various plants.[7] Therefore, 
xylemin (6) is a novel chemical tool to analyze thermospermine 
function and a useful biologically active compound, which can 
manipulate xylem differentiation and organ elongation in plants 
without any genetic modification. Xylem is a source of woody 
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biomass which is of enormous importance for industrial 
applications including pulp and biofuel, therefore, xylemin (6) 
could provide a novel and sustainable method to promote woody 
biomass production with low environmental load. In this full 
paper, we report the improved synthesis of xylemin (6) in 
comparison with the previous synthetic scheme[7] and synthesis 
of various xylemin analogues, and biological effect of their 
synthetic products on xylem and root formation. 
Figure 1. Structure of xylemin (6). 
Results and Discussion 
Synthesis of xylemin (6) 
We commenced the synthesis of xylemin (6) from commercially 
available N-(4-aminobutyl)-2-nitrobenzenesulfonamide (7) as 
shown in Scheme 2. Protection of the amino group of 7 with 
Boc2O/Et3N afforded carbamate 8.[8] Selective alkylation of the 2-
nitrobenzenesulfonamide 8 was performed with 1-bromopropane 
(9)/Cs2CO3/tetrabutylammonium iodide (TBAI) to provide 
propylated product 10.[9] The 2-nitrobenzenesulfonyl (Ns) 
protecting group of 10 was removed with PhSH/Cs2CO3 to give 
amine 11, quantitatively. However, several experiments revealed 
that this reaction has no reproducibility. We observed that this 
reaction proceeded smoothly and thought that the problem might 
result from the purification step by silica gel column 
chromatography. Therefore, we carried out desulfonylation of 10 
by using silica-supported 1-propanethiol (Si-Thiol)[10,11] to 
simplify the purification procedure and the desired amine 11 was 
obtained in 94% yield with reproducibility. Finally, the carbamate 
11 was deprotected with SOCl2 in CH3OH/CH2Cl2[9,12] to furnish 
xylemin (6). The synthetic xylemin (6) was found to promote 
xylem differentiation by the inhibition of thermospermine 
synthesis, as reported in our previous communication.[7] 
Scheme 2. Synthesis of xylemin (6). Ns = 2-nitrobenzenesulfonyl, Boc = tert-
butoxycarbonyl, Et = ethyl, rt = room temperature, TBAI = tetrabutylammonium 
iodide, quant = quantitative, Ph = phenyl. 
Synthesis of xylemin analogues 18–23 
Because it was clarified that xylemin (6) works as the inhibitor of 
thermospermine synthesis, we next decided to synthesize 
xylemin structural analogues and investigate their structure–
activity relationship. Shirahata and co-workers designed N-(3-
aminopropyl)alkylamines as inhibitors of spermine synthase and 
evaluated their activities.[13,14] As summarized in Figure 2, N-(3-
aminopropyl)butylamine (12) exhibited the inhibitory activity 
against spermine synthase with an IC50 value of 0.42 μM. 
Changing the alkyl chain moiety affected the activities. Thus, the 
activity of N-(3-aminopropyl)pentylamine (13) was decreased to 
an IC50 value of  4.2 μM and N-(3-aminopropyl)hexylamine (14) 
was inactive. Shirahata’s group next evaluated the inhibitory 
activities of cycloalkylamines 15–17 and found that N-(3-
aminopropyl)cyclopentylamine (15), N-(3-
aminopropyl)cyclohexylamine (16), and N-(3-
aminopropyl)cycloheptylamine (17) were active with IC50 values 
of 7.5 μM, 0.17 μM, and 1.1 μM, respectively. From these results, 
it was proven that the number of carbons in the substituents on 
nitrogen atom had influence on their inhibitory activities in both 
alkylamines and cycloalkylamines. By using Shirahata’s results 
described above as a reference, we designed and decided to 
synthesize N-(4-aminobutyl)alkylamines 18–23 as xylemin 
structural analogues (Figure 3). 
Figure 2. Inhibitory activity of N-(3-aminopropyl)alkylamines against spermine 
synthase.[13] IC50 = inhibitory concentration in 50% of test subjects. 
Figure 3. Structures of xylemin (6) and its analogues 18–23. 






N-(4-aminobutyl)butylamine (18) and N-(4-
aminobutyl)pentylamine (19) were synthesized by the 
transformation similar to that used for the synthesis of xylemin 
(6). Thus, the butyl and pentyl substituents of amines 25 and 27 
were introduced by Ns strategy (Scheme 3).[9] Subsequently, the 
Ns and Boc moieties were removed by Si-Thiol[10,11] and 
SOCl2/CH3OH,[9,12] respectively, to reach 18 and 19. 
Scheme 3. Synthesis of xylemin analogues 18 (a) and 19 (b). 
We next examined the synthesis of N-(4-
aminobutyl)cyclohexylamine (22). When the alkylation conditions 
with bromocyclohexane (28)/Cs2CO3/TBAI, which were used for 
the synthesis of 6, 18, and 19, were applied to the synthesis of 
cyclohexylamine 30, the reaction did not proceed at all (Scheme 
4a). Condensation of the sulfonamide 8 and cyclohexanol (29) 
under Mitsunobu conditions[15] with diethyl azodicarboxylate 
(DEAD)/Ph3P in toluene at reflux resulted in failure and the 
starting material 8 was recovered (Scheme 4b). Therefore, we 
tried to investigate other synthetic transformations toward the 
synthesis of 22. First, treatment of cyclohexylamine (31) with 
NsCl/NaHCO3[16] afforded the corresponding 
nitrobenzenesulfonamide,[17] which reacted with 4-
bromobutyronitrile (32) in the presence of Cs2CO3 and TBAI[9] to 
provide the alkylated product 33 (Scheme 5a). Deprotection of 
the nitrobenzenesulfonamide 33 with Si-Thiol[10,11] and 
subsequent hydrogenation of the nitrile group with PtO2[17] were 
performed to produce the desired N-(4-
aminobutyl)cyclohexylamine (22).[13] Furthermore, the synthetic 
sequence from 31 to 22 was successfully applied to amines 34, 
36, and 38 to deliver the designed N-(4-aminobutyl)alkylamines 
21,[17] 23, and 20 (Scheme 5b–d). 
Scheme 4. Unsuccessful results for the synthesis of cyclohexylamine 30. 
Scheme 5. Synthesis of xylemin analogues 22 (a), 21 (b), 23 (c), and 20 (d). 
Improved synthesis of xylemin analogues 20–23 
Although we succeeded in the synthesis of xylemin analogues 
20–23, these products were supplied from different amines 38, 
34, 31, and 36 as starting materials, respectively, which resulted 
in increasing the number of total steps for their synthesis. 
Therefore, we next examined the alternative synthetic route for 
obtaining 20–23 more concisely. We first surveyed the reaction 
conditions of mono-reductive amination of cyclohexanone (40) 
with putrescine (2) for delivering N-(4-
aminobutyl)cyclohexylamine (22) in one-step as described in 
Table 1. Treatment of 40 with 2 (2.0 equiv) in the presence of 
Na2SO4 as dehydrating agent and AcOH followed by addition of 
NaBH(OAc)3[18] gave trace amounts of 22 (Entry 1). When the 
reductive amination of 40 with 2 (10 equiv) was carried out by 
using NaBH3CN[19] to afford 22 in 22% yield (Entry 2). 
Bhattacharyya et al. reported the reductive amination of 
aldehydes and ketones utilizing Ti(OiPr)4–NaBH4 reagent 
system.[20] These reaction conditions were successfully applied 
to the synthesis of various secondary amines by Brunel and co-






workers in 2006.[21] When these reaction conditions were used in 
our cases, thus, reaction of 40 with 2 (3.0 equiv) in the presence 
of Ti(OiPr)4 in CH3OH at room temperature and subsequent 
reduction with NaBH4 at –78 °C took place,[22] the desired 
product 22 was produced in 68% yield (Entry 3). Changing the 
reaction temperature from –78 °C to 0 °C in reduction step 
increased the chemical yield of 22 to 84% yield (Entry 4). Having 
succeeded in mono-reductive amination of cyclohexanone (40) 
with putrescine (2) by the combination of Ti(OiPr)4 as a Lewis 
acid and NaBH4 as a reducing reagent, we carried out one-step 
synthesis of xylemin analogues 21,[17] 23, and 20 by the same 
reaction conditions as shown in Scheme 6. 
 
Table 1. Mono-reductive amination of cyclohexanone (40) with putrescine (2). 
Entry Conditions[a] Yield [%][b] 
1 Na2SO4, AcOH, rt, then NaBH(OAc)3, rt N.D.[c] 
2 MS4Å, AcOH, CH3OH, reflux, then 
NaBH3CN, rt 
22 
3 Ti(OiPr)4, CH3OH, rt, then NaBH4, –78 °C 68 
4 Ti(OiPr)4, CH3OH, rt, then NaBH4, 0 °C 84 
[a] Ac = acetyl, MS = molecular sieves, Pr = propyl. [b] Isolated yield. [c] N.D. 
= not determined. Formation of trace amounts of 22 was observed. 
 
Scheme 6. One-step synthesis of xylemin analogues 21 (a), 23 (b), and 20 (c) 
via mono-reductive amination. 
Effect of xylemin (6) and its analogues 18–23 on the 
expression of ACL5 gene 
With xylemin (6) and its analogues 18–23 in hand, we next tried 
to carry out the biological evaluation of these synthetic products. 
First, for the quantitative evaluation of biological activity of the 
synthetic products, we used expression level of the ACL5 gene 
as a sensitive indicator of the endogenous amount of 
thermospermine. The expression level of ACL5 is feedback-
regulated by the amount of thermospermine (5); depletion of 
thermospermine (5) leads to the increased expression of ACL5, 
whereas the increase of thermospermine content causes a 
reduction of ACL5 mRNA.[5b] The transcript level of ACL5 gene 
was quantified in Arabidopsis wild-type seedlings treated with 
xylemin (6), xylemin analogues 18–23, or thermospermine (5) by 
reverse transcription-quantitative polymerase chain reaction 
(RT-qPCR). As expected, the accumulation of ACL5 transcripts 
was significantly increased in seedlings treated with xylemin (6) 
(Figure 4). Interestingly, the expression of ACL5 was also 
promoted to the similar level to that in the case of xylemin (6) by 
adding the xylemin analogue 21, whereas it was not affected 
when the other analogues were added to the culture medium. 
These results have revealed that endogenous thermospermine 
level is decreased by xylemin (6) and its analogue N-(4-
aminobutyl)cyclopentylamine (21). In Shirahata’s work about 
inhibitors of spermine synthase, N-(3-
aminopropyl)cyclohexylamine (16) exhibited the inhibitory 
activity with an IC50 value similar to that of N-(3-
aminopropyl)butylamine (12).[13,14] In our case of inhibitors of 
thermospermine synthase, N-(4-aminobutyl)cyclopentylamine 
(21) was active as well as xylemin (6), N-(4-
aminobutyl)propylamine. It is interesting that the expression 
level of ACL5 is affected by the number of carbons on the 
nitrogen atom, which has the similar tendency to that found in 
inhibitors of spermine synthase. 
Figure 4. Effects of xylemin (6), its analogues 18–23, and thermospermine (5) 
on the expression of thermospermine synthase gene ACAULIS5 (ACL5). Wild 
type seedlings of Arabidopsis thaliana were grown for 7 days in the liquid 
medium without (Mock) or with 6, 18–23, or 5 at the concentration of 200 μM. 
Expression of ACL5 was quantified by reverse transcription-quantitative 
polymerase chain reaction (RT-qPCR). Expression of ACTIN8 (ACT8) was 
used as a control. Columns and error bars indicate mean values and standard 
deviations of n = 3, respectively. Asterisks show significant difference from the 
value of Mock treatment (P < 0.01, t-test). 
Effect of xylemin (6) and its analogues 18–23 on xylem 
formation 
Next, we analyzed effect of xylemin (6) and its analogues 18–23 
on xylem differentiation because inhibition of thermospermine 
synthesis by xylemin triggers excess xylem formation in 
Arabidopsis.[7] Arabidopsis wild-type seedlings were grown 






under the presence of xylemin (6) and xylemin analogues 18–23. 
Xylem formation was observed under a microscope (Figure 5) 
and quantification of xylem differentiation is depicted in Figure 6. 
The addition of xylemin (6) and the xylemin analogue 21 
remarkably promoted xylem formation, whereas the other 
xylemin analogues did not affect the xylem differentiation. Thus, 
N-(4-aminobutyl)cyclopentylamine (21) promotes xylem 
differentiation by inhibiting thermospermine biosynthesis as in 
the case of xylemin (6). 
Recently, crystal structure of thermospermine synthase of a 
leguminous plant Medicago truncatula (MtACL5) has been 
revealed.[23] The binding site of spermidine (3), a precursor of 
thermospermine (5), is narrow and charged negatively. Acidic 
amino acid residues of MtACL5 form hydrogen bonds with 
amino groups of spermidine (3). Aromatic amino acid residues 
generate hydrophobic interactions with 3. The protein structure 
of MtACL5 is applicable to that of Arabidopsis thaliana ACL5, 
because the amino acid sequences of ACL5 are highly 
conserved in plants, especially within flowering plants including 
Medicago and Arabidopsis.[2,4b,24] Thus, relatively compact alkyl 
groups of xylemin (6) and the xylemin analogue 21 may possibly 
be preferred for interactions with the active site of ACL5 protein. 
Figure 5. Effects of xylemin (6) and its analogues 18–23 on xylem 
differentiation. Wild type seedlings of Arabidopsis thaliana were grown for 7 
days in the liquid medium without (Mock) or with 6 or 18–23 at the 
concentration of 200 μM. Hypocotyls were observed under a differential 
interference contrast microscope. The region between white triangles indicates 
xylem vessels, which exhibit brown color due to secondary cell wall thickening 
and lignin deposition. 
Figure 6. Quantification of xylem differentiation. The width of xylem was 
quantified in the hypocotyls of Arabidopsis wild type seedlings shown in Figure 
5. Data were represented with box plots. The number of plants used for 
quantification (n) in each treatment was shown under horizontal axis labels. 
Asterisks show significant difference from the value of Mock treatment (P < 
0.0003, t-test). 
Effect of xylemin (6) and its analogues 18–23 on lateral root 
formation 
Our previous study has shown that xylemin (6) promotes the 
formation of lateral roots, whereas thermospermine suppresses 
it.[7] Therefore, we examined effects of xylemin analogues  18–
23 on lateral root formation (Figure 7). Xylemin (6)  significantly 
promoted lateral root formation, whereas xylemin analogues 18–
23 including the analogue 21 did not. In consideration with the 
similar effect of xylemin (6) and the analogue 21 on ACL5 
expression and xylem formation, the physiological action of 6 
and 21 may differ in lateral root formation. 
Figure 7. Effects of xylemin (6), its analogues 18–23, and thermospermine (5) 
on lateral root formation. Wild type seedlings of Arabidopsis thaliana were 
grown for 7 days on the agar medium without (Mock) or with 6, 18–23, or 5 at 
the concentration of 100 μM. Seedlings were observed under a 
stereomicroscope. The number of lateral roots per plant was measured. The 
number of plants used for quantification (n) in each treatment was shown 
under horizontal axis labels. Columns and error bars indicate mean values and 
the standard errors, respectively. Single and double asterisks show significant 
difference from the value of Mock treatment at the P level less than 0.03 and 
0.003, respectively (t-test). 
Conclusions 
First, chemical synthesis of xylemin (6) and its designed 
structural analogues 18–23 was examined. Xylemin (6) and N-
(4-aminobutyl)alkylamines 18–23 were successfully synthesized 
by utilizing Ns strategy. In addition, improvement of the 
synthesis of 20–23 was carried out to result in the synthesis of 
these analogues in one-step via mono-reductive amination of 
the corresponding ketones, respectively. This concise synthesis 
by mono-reductive amination of ketones could be applied to the 
synthesis of polyamines including other xylemin analogues. Next, 
we evaluated the biological effect of synthetic molecules. 
Xylemin (6) and the xylemin analogue 21, N-(4-
aminobutyl)cyclopentylamine, exhibited significant biological 






activity to promote xylem formation. Enhanced transcript 
accumulation of thermospermine synthase gene ACL5 by the 
addition of 6 or 21 supports their inhibitory effects on 
biosynthesis of thermospermine. Other xylemin analogues (18–
20, 22, 23) did not affect xylem formation and transcript level of 
ACL5. These differential effects may be due to larger alkyl 
groups of the xylemin analogues 18–20, 22, and 23 than 6 and 
21. Thus, the size and structure of the alkyl group are essential 
for the activity to enhance xylem formation. Xylemin (6) 
promoted lateral root formation, whereas the xylemin analogue 
21 did not. This may reflect mild effect of 21 on xylem 
differentiation. Lateral roots develop from pericycle cell layer, 
which locates outside of vascular tissues. Pericycles in contact 
with inner xylem region (xylem-pole pericycles) preferentially 
generate lateral roots. Xylemin (6) enhances xylem formation, 
which probably causes increased number of xylem-pole 
pericycles and lateral roots, whereas xylem formation enhanced 
by the xylemin analogue 21 is not enough to increase xylem-
pole pericycles. Thus, the analogue 21 could be utilized as a 
novel inhibitor of thermospermine synthesis, which specifically 
promotes xylem formation. 
Experimental Section 
General Methods: Reagents were used as received from commercial 
suppliers unless otherwise indicated. All reactions were carried out under 
an atmosphere of argon. Reaction solvents were purchased as 
dehydrated solvents and stored with active molecular sieves 4Å under 
argon prior to use for reactions. All solvents for work-up procedure were 
used as received. Analytical thin-layer chromatography (TLC) was 
performed with aluminium TLC plates (Merck TLC silica gel 60F254). 
Column chromatography was performed with Fuji Silysia silica gel BW-
300 or Kanto Chemical silica gel 60N. Kugelrohr distillation was 
performed with Shibata Glass Tube Oven GTO-250RS. IR spectra were 
recorded on JASCO FT/IR-460 plus. 1H and 13C NMR spectra were 
recorded on JEOL JNM-AL400 or Varian 400-MR. Chemical shifts in the 
NMR spectra are reported in ppm with reference to the internal residual 
solvent (1H NMR, CDCl3 7.26 ppm, D2O 4.79 ppm, CD3OD 3.31 ppm; 13C 
NMR, CDCl3 77.0 ppm, CD3OD 49.0 ppm, (CD3)2SO 39.5 ppm). The 
following abbreviations are used to designate the multiplicities: s = singlet, 
t = triplet, q = quartet, quin = quintet, m = multiplet, br = broad. Coupling 
constants (J) are in hertz. High resolution mass spectra were recorded 
on Waters Micromass LCT (ESI–TOF–MS) or Bruker micOTOF II (ESI–
TOF–MS). 
Carbamate 8: To a solution of N-(4-aminobutyl)-2-
nitrobenzenesulfonamide (7) (200 mg, 0.732 mmol) in CH2Cl2 (5.0 mL) 
were added Et3N (0.12 mL, 0.878 mmol) and Boc2O (0.20 mL, 0.878 
mmol) at room temperature. The mixture was stirred at the same 
temperature for 2 h. The mixture was diluted with CH2Cl2 and washed 
with 1N aqueous HCl. The aqueous phase was extracted with CH2Cl2 
twice and the combined organic phase was washed with brine and dried 
over Na2SO4. Concentration and column chromatography (hexane/EtOAc 
= 2:1, 1:1) gave carbamate 8 (269 mg, 98%): yellow solid; Rf = 0.27 
(hexane/EtOAc = 1:1); IR (neat) 3294, 3085, 2980, 1703, 1676 cm–1; 1H 
NMR (400 MHz, CDCl3) δ 8.14–8.12 (m, 1 H), 7.87–7.85 (m, 1 H), 7.76–
7.73 (m, 2 H), 5.36 (brs, 1 H), 4.54 (brs, 1 H), 3.13–3.06 (m, 4 H), 1.61–
1.47 (m, 4 H), 1.42 (s, 9 H); 13C NMR (100 MHz, CDCl3) δ 156.0, 148.1, 
133.6, 133.6, 132.8, 131.1, 125.4, 79.3, 43.4, 39.8, 28.4, 27.1, 26.8; 
HRMS (ESI–TOF) calcd for C15H23N3O6SNa [M + Na]+ 396.1205, found 
396.1201. 
Sulfonamide 10: To a solution of sulfonamide 8 (1.02 g, 2.73 mmol) in 
CH3CN (7.8 mL) were added Cs2CO3 (2.69 g, 8.26 mmol), TBAI (506 mg, 
1.37 mmol), and 1-bromopropane (9, 0.30 mL, 3.28 mmol) at room 
temperature. The mixture was stirred at 40 °C for 2 h. To the mixture was 
added 1-bromopropane (9, 0.30 mL, 3.28 mmol) at room temperature. 
The mixture was stirred at 40 °C for 1 h. The mixture was diluted with 
EtOAc and washed with H2O. The aqueous phase was extracted with 
EtOAc three times and the combined organic phase was washed with 
brine and dried over Na2SO4. Concentration and column chromatography 
(hexane/EtOAc = 4:1, 1:1) gave sulfonamide 10 (1.15 g, quant): yellow 
oil; Rf = 0.52 (hexane/EtOAc = 1:1); IR (neat) 3412, 3094, 2971, 2934, 
2876, 1699 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.01–7.99 (m, 1 H), 7.68–
7.66 (m, 2 H), 7.61–7.59 (m, 1 H), 4.53 (brs, 1 H), 3.30 (t, J = 7.6 Hz, 2 
H), 3.23 (t, J = 7.6 Hz, 2 H), 3.10 (q, J = 7.6 Hz, 2 H), 1.60–1.46 (m, 6 H), 
1.44 (s, 9 H), 0.85 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 
155.9, 148.0, 133.7, 133.2, 131.4, 130.6, 124.0, 79.2, 49.1, 47.0, 40.0, 
28.5, 27.3, 25.6, 21.5, 11.1; HRMS (ESI–TOF) calcd for C18H29N3O6SNa 
[M + Na]+ 438.1675, found 438.1678. 
Deprotection of Sulfonamide 10 with PhSH: To a solution of 
sulfonamide 10 (11.3 mg, 27.2 μmol) in CH3CN (0.8 mL) were added 
Cs2CO3 (44.3 mg, 0.136 mmol) and PhSH (10 μL, 0.101 mmol) at room 
temperature. The mixture was stirred at the same temperature for 3 h. 
The mixture was filtered through a Celite pad and washed with EtOAc. 
Concentration and column chromatography (CH2Cl2, CH2Cl2/CH3OH = 
5:1 including 2% Et3N) gave amine 11 (6.8 mg, quant): yellow oil; Rf = 
0.15 (CH2Cl2/CH3OH = 5:1); IR (neat) 3340, 2962, 2932, 2873, 1697 cm–
1; 1H NMR (400 MHz, CD3OD) δ 3.04–3.03 (m, 2 H), 2.56–2.49 (m, 4 H), 
1.54–1.48 (m, 6 H), 1.41 (s, 9 H), 0.95–0.89 (m, 3 H); 13C NMR (100 MHz, 
CD3OD) δ 158.4, 79.7, 52.6, 50.3, 41.2, 28.8, 27.7, 23.5, 12.1; HRMS 
(ESI–TOF) calcd for C12H27N2O2 [M + H]+ 231.2073, found 231.2072. 
Deprotection of Sulfonamide 10 with Si-Thiol: To a solution of 
sulfonamide 10 (700 mg, 1.68 mmol) in CH3CN (17 mL) were added 
Cs2CO3 (1.64 g, 5.04 mmol) and Si-Thiol (1.3 mmol/g, 5.24 g, 6.81 mmol) 
at room temperature. The mixture was stirred at 80 °C for 5 h. The 
mixture was filtered through a Celite pad and washed with EtOAc. 
Concentration gave amine 11 (365 mg, 94%). 
Xylemin (6): To a solution of carbamate 11 (92.2 mg, 0.400 mmol) in 
CH3OH (2.6 mL) and CH2Cl2 (1.3 mL) was added SOCl2 (0.260 mL, 3.60 
mmol) at 0 °C. The mixture was stirred at room temperature for 5 h. 
Concentration gave xylemin (6, 131 mg, quant): yellow solid; IR (neat) 
3422, 2930, 2778 cm–1; 1H NMR (400 MHz, D2O) δ 3.13–3.02 (m, 6 H), 
1.81–1.68 (m, 6 H), 1.00 (t, J = 7.6 Hz, 3 H); 13C NMR (100 MHz, 
CD3CD) δ 50.6, 48.1, 40.1, 25.6, 24.3, 20.7, 11.3; HRMS (ESI–TOF) 
calcd for C7H19N2 [M + H]+ 131.1548, found 131.1550. 
N-(4-Aminobutyl)butylamine (18): To a solution of sulfonamide 8 (30.6 
mg, 81.9 μmol) in CH3CN (1.0 mL) were added Cs2CO3 (80.2 mg, 0.246 
mmol), TBAI (15.1 mg, 41.0 μmol), and 1-bromobutane (24, 11 μL, 98.3 
μmol) at room temperature. The mixture was stirred at 40 °C for 3 h. To 
the mixture was added 1-bromobutane (24, 21 μL, 0.197 mmol) at room 
temperature. The mixture was stirred at 40 °C for 2 h. The mixture was 
diluted with EtOAc and washed with H2O. The aqueous phase was 
extracted with EtOAc three times and the combined organic phase was 
washed with brine and dried over Na2SO4. Concentration and short 
column chromatography (hexane/EtOAc = 2:1) gave sulfonamide 25 
(32.5 mg), which was used for the next step without further purification. 
To a solution of sulfonamide 25 obtained above (32.5 mg) in CH3CN (1.0 
mL) were added Cs2CO3 (77.0 mg, 0.236 mmol) and Si-Thiol (1.3 mmol/g, 






233 mg, 0.303 mmol) at room temperature. The mixture was stirred at 
80 °C for 7 h. The mixture was filtered through a Celite pad and washed 
with EtOAc. Concentration gave the corresponding amine (18.2 mg), 
which was used for the next step without further purification. To a 
solution of the carbamate obtained above (18.2 mg) in CH3OH (0.8 mL) 
and CH2Cl2 (0.4 mL) was added SOCl2 (48 μL, 0.652 mmol) at 0 °C. The 
mixture was stirred at room temperature for 5 h. Concentration gave N-
(4-aminobutyl)butylamine (18, 15.0 mg, quant in three steps): yellow 
solid; IR (neat) 3395, 2966 cm–1; 1H NMR (400 MHz, D2O) δ 3.12–3.07 
(m, 6 H), 1.81–1.79 (m, 4 H), 1.73–1.66 (m, 2 H), 1.43 (q, J = 6.8 Hz, 2 
H), 0.96 (t, J = 6.8 Hz, 3 H); 13C NMR (100 MHz, CD3OD) δ 49.9, 48.2, 
40.1, 29.2, 25.6, 24.3, 20.8, 13.9; HRMS (ESI–TOF) calcd for C8H21N2 [M 
+ H]+ 145.1705, found 145.1710. 
N-(4-Aminobutyl)pentylamine (19): To a solution of sulfonamide 8 
(33.1 mg, 88.6 μmol) in CH3CN (1.0 mL) were added Cs2CO3 (86.7 mg, 
0.266 mmol), TBAI (16.4 mg, 44.3 μmol), and 1-bromopentane (26, 13 
μL, 0.106 mmol) at room temperature. The mixture was stirred at 40 °C 
for 1 h. To the mixture was added 1-bromopentane (26, 39 μL, 0.315 
mmol) at room temperature. The mixture was stirred at 60 °C for 1 h. The 
mixture was diluted with EtOAc and washed with H2O. The aqueous 
phase was extracted with EtOAc three times and the combined organic 
phase was washed with brine and dried over Na2SO4. Concentration and 
short column chromatography (hexane/EtOAc = 4:1, 2:1) gave 
sulfonamide 27 (33.9 mg), which was used for the next step without 
further purification. To a solution of sulfonamide 27 obtained above (33.9 
mg) in CH3CN (1.0 mL) were added Cs2CO3 (74.6 mg, 0.229 mmol) and 
Si-Thiol (1.3 mmol/g, 235 mg, 0.306 mmol) at room temperature. The 
mixture was stirred at 80 °C for 8 h. The mixture was filtered through a 
Celite pad and washed with EtOAc. Concentration gave the 
corresponding amine (20.5 mg), which was used for the next step without 
further purification. To a solution of the carbamate obtained above (20.5 
mg) in CH3OH (0.8 mL) and CH2Cl2 (0.4 mL) was added SOCl2 (52 μL, 
0.713 mmol) at 0 °C. The mixture was stirred at room temperature for 5 h. 
Concentration gave N-(4-aminobutyl)pentylamine (19, 20.4 mg, quant in 
three steps): yellow solid; IR (neat) 3409, 2963 cm–1; 1H NMR (400 MHz, 
D2O) δ 3.12–3.06 (m, 6 H), 1.81–1.68 (m, 6 H), 1.39–1.37 (m, 4 H), 0.95–
0.91 (m, 3 H); 13C NMR (100 MHz, CD3OD) δ 49.6, 48.2, 40.1, 29.7, 27.0, 
25.7, 24.3, 23.2, 14.1; HRMS (ESI–TOF) calcd for C9H23N2 [M + H]+ 
160.1891, found 160.1886. 
Nitrile 33: To a solution of cyclohexylamine (31, 0.10 mL, 0.877 mmol) in 
THF (8.8 mL) were added NaHCO3 (298 mg, 3.58 mmol) and NsCl (400 
mg, 1.80 mmol) at 0 °C. The mixture was stirred at the same temperature 
for 10 min. The reaction was quenched with 3N aqueous NaOH. The 
mixture was stirred at room temperature for 1 h. The mixture was diluted 
with EtOAc, washed with saturated 3N aqueous NaOH, 3N aqueous HCl, 
and brine, and then dried over Na2SO4. Concentration and short column 
chromatography (hexane/EtOAc = 4:1) gave the corresponding 
sulfonamide (273 mg), which was used for the next step without further 
purification. To a solution of the sulfonamide obtained above (273 mg) in 
CH3CN (9.6 mL) were added Cs2CO3 (940 mg, 2.89 mmol), TBAI (178 
mg, 0.482 mmol), and 4-bromobutyronitrile (32, 0.11 mL, 1.11 mmol) at 
room temperature. The mixture was stirred at 60 °C for 2 h. To the 
mixture was added 4-bromobutyronitrile (32, 0.22 mL, 2.22 mmol) at 
room temperature. The mixture was stirred at 60 °C for 1 h. The mixture 
was diluted with EtOAc and washed with H2O. The aqueous phase was 
extracted with EtOAc twice and the combined organic phase was washed 
with brine and dried over Na2SO4. Concentration and column 
chromatography (hexane/EtOAc = 5:1, 2:1) gave nitrile 33 (340 mg, 
quant in two steps): yellow oil; Rf = 0.44 (hexane/EtOAc = 1:1); IR (neat) 
3095, 2935, 2859, 2246, 1734 cm–1; 1H NMR (400 MHz, CDCl3) δ 8.04–
8.01 (m, 1 H), 7.73–7.59 (m, 3 H), 3.72–3.65 (m, 1 H), 3.37 (t, J = 7.6 Hz, 
2 H), 2.42 (t, J = 7.0 Hz, 2 H), 2.02 (quin, J = 7.0 Hz, 2 H), 1.80–1.60 (m, 
5 H), 1.44–1.26 (m, 4 H), 1.12–1.01 (m, 1 H); 13C NMR (100 MHz, 
CDCl3) δ 148.0, 133.6, 133.5, 131.5, 130.7, 124.1, 118.9, 58.5, 42.7, 
32.0, 27.6, 26.0, 25.2, 14.8; HRMS (ESI–TOF) calcd for C16H21N3O4SNa 
[M + Na]+ 374.1151, found 374.1144. 
N-(4-Aminobutyl)cyclohexylamine (22): To a solution of sulfonamide 
33 (15.2 mg, 43.3 μmol) in CH3CN (1.4 mL) were added Cs2CO3 (44.1 
mg, 0.135 mmol) and Si-Thiol (1.3 mmol/g, 133 mg, 0.173 mmol) at room 
temperature. The mixture was stirred at 80 °C for 6 h. The mixture was 
filtered through a Celite pad and washed with EtOAc. Concentration gave 
the corresponding amine (6.7 mg), which was used for the next step 
without further purification. A mixture of the nitrile obtained above (6.7 
mg) and PtO2 (0.9 mg, 4.03 μmol) in EtOH (1.0 mL) and CHCl3 (0.1 mL) 
was stirred for 20 h under a H2 atmosphere at room temperature. The 
mixture was filtered and washed with CH3OH. Concentration gave N-(4-
aminobutyl)cyclohexylamine (22, 8.4 mg, quant in two steps). 
N-(4-Aminobutyl)cyclopentylamine (21): To a solution of 
cyclopentylamine (34, 20 μL, 0.202 mmol) in THF (2.0 mL) were added 
NaHCO3 (67.9 mg, 0.808 mmol) and NsCl (89.5 mg, 0.404 mmol) at 0 °C. 
The mixture was stirred at the same temperature for 10 min. The reaction 
was quenched with 3N aqueous NaOH. The mixture was stirred at room 
temperature for 30 min. The mixture was diluted with EtOAc, washed 
with saturated 3N aqueous NaOH, 3N aqueous HCl, and brine, and then 
dried over Na2SO4. Concentration and short column chromatography 
(hexane/EtOAc = 4:1) gave the corresponding sulfonamide (51.8 mg), 
which was used for the next step without further purification. To a 
solution of the sulfonamide obtained above (51.8 mg) in CH3CN (1.9 mL) 
were added Cs2CO3 (188 mg, 0.576 mmol), TBAI (35.5 mg, 96.0 μmol), 
and 4-bromobutyronitrile (32, 23 μL, 0.230 mmol) at room temperature. 
The mixture was stirred at 60 °C for 20 min. To the mixture was added 4-
bromobutyronitrile (32, 46 μL, 0.460 mmol) at room temperature. The 
mixture was stirred at 60 °C for 1 h. The mixture was diluted with EtOAc 
and washed with H2O. The aqueous phase was extracted with EtOAc 
twice and the combined organic phase was washed with brine and dried 
over Na2SO4. Concentration and short column chromatography 
(hexane/EtOAc = 4:1, 2:1) gave nitrile 35 (56.5 mg), which was used for 
the next step without further purification. To a solution of sulfonamide 35 
obtained above (56.5 mg) in CH3CN (5.6 mL) were added Cs2CO3 (163 
mg, 0.501 mmol) and Si-Thiol (1.3 mmol/g, 514 mg, 0.668 mmol) at room 
temperature. The mixture was stirred at 80 °C for 6 h. The mixture was 
filtered through a Celite pad and washed with EtOAc. Concentration gave 
the corresponding amine (24.7 mg), which was used for the next step 
without further purification. A mixture of the nitrile obtained above (24.7 
mg) and PtO2 (3.6 mg, 15.7 μmol) in EtOH (3.1 mL) and CHCl3 (0.3 mL) 
was stirred for 20 h under a H2 atmosphere at room temperature. The 
mixture was filtered and washed with CH3OH. Concentration gave N-(4-
aminobutyl)cyclopentylamine (21, 35.5 mg, quant in four steps). 
N-(4-Aminobutyl)cycloheptylamine (23): To a solution of 
cycloheptylamine (36, 25 μL, 0.197 mmol) in THF (2.0 mL) were added 
NaHCO3 (65.2 mg, 0.776 mmol) and NsCl (87.3 mg, 0.394 mmol) at 0 °C. 
The mixture was stirred at the same temperature for 10 min. The reaction 
was quenched with 3N aqueous NaOH. The mixture was stirred at room 
temperature for 30 min. The mixture was diluted with EtOAc, washed 
with saturated 3N aqueous NaOH, 3N aqueous HCl, and brine, and then 
dried over Na2SO4. Concentration and short column chromatography 
(hexane/EtOAc = 4:1) gave the corresponding sulfonamide (65.2 mg), 
which was used for the next step without further purification. To a 
solution of the sulfonamide obtained above (65.2 mg) in CH3CN (2.2 mL) 
were added Cs2CO3 (214 mg, 0.657 mmol), TBAI (29.6 mg, 80.1 μmol), 
and 4-bromobutyronitrile (32, 26 μL, 0.263 mmol) at room temperature. 
The mixture was stirred at 60 °C for 1 h. To the mixture was added 4-
bromobutyronitrile (32, 52 μL, 0.526 mmol) at room temperature. The 






mixture was stirred at 60 °C for 1 h. The mixture was diluted with EtOAc 
and washed with H2O. The aqueous phase was extracted with EtOAc 
twice and the combined organic phase was washed with brine and dried 
over Na2SO4. Concentration and short column chromatography 
(hexane/EtOAc = 2:1) gave nitrile 37 (78.4 mg), which was used for the 
next step without further purification. To a solution of sulfonamide 37 
obtained above (78.4 mg) in CH3CN (6.5 mL) were added Cs2CO3 (190 
mg, 0.582 mmol) and Si-Thiol (1.3 mmol/g, 597 mg, 0.776 mmol) at room 
temperature. The mixture was stirred at 80 °C for 6 h. The mixture was 
filtered through a Celite pad and washed with EtOAc. Concentration gave 
the corresponding amine (33.3 mg), which was used for the next step 
without further purification. A mixture of the nitrile obtained above (33.3 
mg) and PtO2 (4.2 mg, 18.5 μmol) in EtOH (3.7 mL) and CHCl3 (0.2 mL) 
was stirred for 20 h under a H2 atmosphere at room temperature. The 
mixture was filtered and washed with CH3OH. Concentration gave N-(4-
aminobutyl)cycloheptylamine (23, 44.1 mg, quant in four steps). 
N-(4-Aminobutyl)-1-ethylpropylamine (20): To a solution of 1-
ethylpropylamine (38, 25 μL, 0.215 mmol) in THF (2.2 mL) were added 
NaHCO3 (72.2 mg, 0.860 mmol) and NsCl (95.3 mg, 0.430 mmol) at 0 °C. 
The mixture was stirred at the same temperature for 20 min. The reaction 
was quenched with 3N aqueous NaOH. The mixture was stirred at room 
temperature for 1 h. The mixture was diluted with EtOAc, washed with 
saturated 3N aqueous NaOH, 3N aqueous HCl, and brine, and then dried 
over Na2SO4. Concentration and short column chromatography 
(hexane/EtOAc = 4:1) gave the corresponding sulfonamide (55.4 mg), 
which was used for the next step without further purification. To a 
solution of the sulfonamide obtained above (55.4 mg) in CH3CN (2.0 mL) 
were added Cs2CO3 (217 mg, 0.666 mmol), TBAI (31.0 mg, 83.9 μmol), 
and 4-bromobutyronitrile (32, 24 μL, 0.242 mmol) at room temperature. 
The mixture was stirred at 60 °C for 2 h. To the mixture was added 4-
bromobutyronitrile (32, 48 μL, 0.484 mmol) at room temperature. The 
mixture was stirred at 60 °C for 1 h. The mixture was diluted with EtOAc 
and washed with H2O. The aqueous phase was extracted with EtOAc 
three times and the combined organic phase was washed with brine and 
dried over Na2SO4. Concentration and short column chromatography 
(hexane/EtOAc = 2:1) gave nitrile 39 (66.3 mg), which was used for the 
next step without further purification. To a solution of sulfonamide 39 
obtained above (66.3 mg) in CH3CN (6.5 mL) were added Cs2CO3 (201 
mg, 0.616 mmol) and Si-Thiol (1.3 mmol/g, 600 mg, 0.780 mmol) at room 
temperature. The mixture was stirred at 80 °C for 7 h. The mixture was 
filtered through a Celite pad and washed with EtOAc. Concentration gave 
the corresponding amine (29.1 mg), which was used for the next step 
without further purification. A mixture of the nitrile obtained above (29.1 
mg) and PtO2 (4.3 mg, 18.9 μmol) in EtOH (3.8 mL) and CHCl3 (0.2 mL) 
was stirred for 20 h under a H2 atmosphere at room temperature. The 
mixture was filtered and washed with CH3OH. Concentration gave N-(4-
aminobutyl)-1-ethylpropylamine (20, 40.3 mg, quant in four steps). 
One-Step Synthesis of N-(4-Aminobutyl)cyclohexylamine (22) via 
Mono-Reductive Amination: To a solution of cyclohexanone (40, 0.25 
mL, 2.42 mmol) in CH3OH (15 mL) were added putrescine (2, 0.68 mL, 
7.26 mmol) and Ti(OiPr)4 (0.93 mL, 3.15 mmol) at room temperature. The 
mixture was stirred at the same temperature for 3 h. To the mixture was 
added NaBH4 (98.7 mg, 2.61 mmol) at 0 °C. The mixture was stirred at 
the same temperature for 30 min. The reaction was quenched with H2O. 
The mixture was stirred at room temperature for 20 min. The mixture was 
filtered through a Celite pad and washed with EtOAc. The mixture was 
washed with 3N aqueous NaOH. The aqueous phase was extracted with 
EtOAc three times and the combined organic phase was washed with 
basic brine (pH = 11 by adding aqueous NaOH) and dried over Na2SO4. 
Concentration and kugelrohr distillation (9 mmHg, 140–155 °C) gave N-
(4-aminobutyl)cyclohexylamine (22, 346 mg, 84%): colorless oil; IR (neat) 
3358, 3281, 2926, 2852 cm–1; 1H NMR (400 MHz, CD3OD) δ 2.65–2.57 
(m, 4 H), 2.46–2.39 (m, 1 H), 1.92–1.64 (m, 5 H), 1.53–1.47 (m, 4 H), 
1.34–1.06 (m, 5 H); 13C NMR (100 MHz, (CD3)2SO) δ 55.7, 42.6, 37.9, 
28.3, 24.7, 24.1, 23.9, 22.5; HRMS (ESI–TOF) calcd for C10H23N2 [M + 
H]+ 171.1861, found 171.1859. 
One-Step Synthesis of N-(4-Aminobutyl)cyclopentylamine (21) via 
Mono-Reductive Amination: To a solution of cyclopentanone (41, 0.25 
mL, 2.82 mmol) in CH3OH (18 mL) were added putrescine (2, 0.79 mL, 
8.46 mmol) and Ti(OiPr)4 (1.1 mL, 3.67 mmol) at room temperature. The 
mixture was stirred at the same temperature for 3 h. To the mixture was 
added NaBH4 (106 mg, 2.82 mmol) at 0 °C. The mixture was stirred at 
the same temperature for 30 min. The reaction was quenched with H2O. 
The mixture was stirred at room temperature for 20 min. The mixture was 
filtered through a Celite pad and washed with EtOAc. The mixture was 
washed with 3N aqueous NaOH. The aqueous phase was extracted with 
EtOAc three times and the combined organic phase was washed with 
basic brine (pH = 11 by adding aqueous NaOH) and dried over Na2SO4. 
Concentration and kugelrohr distillation (9 mmHg, 115–130 °C) gave N-
(4-aminobutyl)cyclopentylamine (21, 320 mg, 73%): colorless oil; IR 
(neat) 3370, 3279, 2950, 2860 cm–1; 1H NMR (400 MHz, CD3OD) δ 3.04 
(quin, J = 7.2 Hz, 1 H), 2.64 (t, J = 6.8 Hz, 2 H), 2.57 (t, J = 6.8 Hz, 2 H), 
1.92–1.29 (m, 14 H); 13C NMR (100 MHz, (CD3)2SO) δ 58.1, 44.8, 37.9, 
28.9, 24.0, 23.5, 22.5; HRMS (ESI–TOF) calcd for C9H21N2 [M + H]+ 
157.1705, found 157.1698. 
One-Step Synthesis of N-(4-Aminobutyl)cycloheptylamine (23) via 
Mono-Reductive Amination: To a solution of cycloheptanone (42, 0.30 
mL, 2.54 mmol) in CH3OH (16 mL) were added putrescine (2, 0.71 mL, 
7.62 mmol) and Ti(OiPr)4 (0.97 mL, 3.30 mmol) at room temperature. The 
mixture was stirred at the same temperature for 3 h. To the mixture was 
added NaBH4 (101 mg, 2.67 mmol) at 0 °C. The mixture was stirred at 
the same temperature for 30 min. The reaction was quenched with H2O. 
The mixture was stirred at room temperature for 20 min. The mixture was 
filtered through a Celite pad and washed with EtOAc. The mixture was 
washed with 3N aqueous NaOH. The aqueous phase was extracted with 
EtOAc three times and the combined organic phase was washed with 
basic brine (pH = 11 by adding aqueous NaOH) and dried over Na2SO4. 
Concentration and kugelrohr distillation (9 mmHg, 150–165 °C) gave N-
(4-aminobutyl)cycloheptylamine (23, 428 mg, 92%): colorless oil; IR 
(neat) 3362, 3282, 2923, 2853 cm–1; 1H NMR (400 MHz, CD3OD) δ 2.65–
2.55 (m, 5 H), 1.92–1.35 (m, 19 H); 13C NMR (100 MHz, (CD3)2SO) δ 
57.9, 43.1, 37.9, 30.0, 29.0, 27.3, 27.1, 23.3; HRMS (ESI–TOF) calcd for 
C11H25N2 [M + H]+ 185.2018, found 185.2019. 
One-Step Synthesis of N-(4-Aminobutyl)-1-ethylpropylamine (20) via 
Mono-Reductive Amination: To a solution of 3-pentanone (43, 0.30 mL, 
2.86 mmol) in CH3OH (18 mL) were added putrescine (2, 0.80 mL, 8.58 
mmol) and Ti(OiPr)4 (1.1 mL, 3.72 mmol) at room temperature. The 
mixture was stirred at the same temperature for 3 h. To the mixture was 
added NaBH4 (108 mg, 2.86 mmol) at 0 °C. The mixture was stirred at 
the same temperature for 30 min. The reaction was quenched with H2O. 
The mixture was stirred at room temperature for 20 min. The mixture was 
filtered through a Celite pad and washed with EtOAc. The mixture was 
washed with 3N aqueous NaOH. The aqueous phase was extracted with 
EtOAc three times and the combined organic phase was washed with 
basic brine (pH = 11 by adding aqueous NaOH) and dried over Na2SO4. 
Concentration and kugelrohr distillation (9 mmHg, 110–125 °C) gave N-
(4-aminobutyl)-1-ethylpropylamine (20, 325 mg, 72%): colorless oil; IR 
(neat) 3362, 3292, 2928, 2872 cm–1; 1H NMR (400 MHz, CD3OD) δ 2.67–
2.56 (m, 4 H), 2.38 (quin, J = 6.0 Hz, 1 H), 1.52–1.43 (m, 10 H), 0.92–
0.75 (m, 7 H); 13C NMR (100 MHz, (CD3)2SO) δ 59.0, 43.3, 37.9, 24.1, 
22.7, 22.4, 21.3, 21.1, 9.0; HRMS (ESI–TOF) calcd for C9H23N2 [M + H]+ 
159.1861, found 159.1855. 






RT-qPCR: Wild type seedlings of Arabidopsis thaliana (Columbia 
accession) were grown for 7 days in 670 µl of Murashige-Skoog liquid 
medium without (Mock) or with xylemin, xylemin analogues, or 
thermospermine at the concentration of 200 µM. Total RNA was isolated 
by NucleoSpin® RNA Plant RNA isolation kit (TaKaRa) according to the 
manufacture instruction. 0.5 µg of total RNA of each sample was reverse 
transcribed to cDNA by ReverTra Ace reverse transcriptase (TOYOBO) 
according to the manufacture protocol. Quantitative PCR was performed 
in Thermal Cycler Dice Real Time System Lite (TaKaRa) using KOD 
SYBR qPCR Mix (TOYOBO) and gene-specific primers (ACL5: 5’-
ACCGT TAACC AGCGA TGCTT T-3’ and 5’-CCGTT AACTC TCTCT 
TTGAT TCTTC GATCC-3’, and ACT8: 5’-GTGAG CCAGA TCTTC 
ATTCG TC-3’ and 5’-TCTCT TGCTC GTAGT CGACA G-3’). ACT8 was 
used as a reference gene for normalization of transcript abundance. RT-
qPCR was conducted in three biological replicates. 
Observation and Measurement of Xylem Formation: Wild type 
seedlings of Arabidopsis thaliana (Columbia accession) were grown for 7 
days in 670 µl of Murashige-Skoog liquid medium without (Mock) or with 
xylemin, xylemin analogues, or thermospermine at the concentration of 
200 µM. Seedlings were fixed in a solution of 9:1 mixture of ethanol and 
acetic acid, cleared in a mixture of chloral hydrate, glycerol, and water 
solution (8 g : 1 mL : 2 mL), and observed under a differential 
interference contrast microscope (Leica DM5000B) with a CCD camera 
(Leica DFC500). The width of xylem in the hypocotyls was quantified by 
NIH ImageJ software. 
Observation and Measurement of Lateral Root Formation: Wild type 
seedlings of Arabidopsis thaliana (Columbia accession) were grown 
vertically for 7 days on Murashige-Skoog agar medium without (Mock) or 
with xylemin, xylemin analogues, or thermospermine at the concentration 
of 100 µM. Seedlings were observed under a stereomicroscope to count 
the number of lateral roots. 
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Xylemin and its six designed analogues were successfully synthesized. Evaluation of their biological effect on xylem revealed that a 
xylemin analogue, N-(4-aminobutyl)cyclopentylamine, could be a novel inhibitor of thermospermine synthesis to enhance specifically 
xylem formation. 
 
 
